Lightbridge Corp.

  • Market Cap: N/A
  • Industry: Specialty Chemicals
  • ISIN: US53224K3023
USD
17.79
2.07 (13.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Lightbridge Corp. stock-summary
stock-summary
Lightbridge Corp.
Specialty Chemicals
Lightbridge Corporation is a nuclear fuel technology company. The Company participates in the nuclear power industry in the United States and internationally. Its segments include nuclear fuel technology business and nuclear energy consulting business. The nuclear fuel technology business develops next generation nuclear fuel technology that increases the power output of commercial reactors; generates nuclear energy and the amount of nuclear waste on a per-megawatt-hour basis, and enhances reactor safety and the proliferation resistance of spent fuel. The nuclear energy consulting business segment provides nuclear power consulting and strategic advisory services to commercial and governmental entities across the world. It provides integrated strategic advice across a range of areas, including, regulatory development, nuclear reactor site selection, procurement and deployment, reactor and fuel technology, international relations, program management and infrastructure development.
Company Coordinates stock-summary
Company Details
11710 Plaza America Drive, Suite 2000 , RESTON VA : 20190
stock-summary
Tel: 1 571 7301200
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (6.12%)

Foreign Institutions

Held by 19 Foreign Institutions (5.4%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Amb. Thomas Graham
Chairman of the Board, Corporate Secretary
Mr. Seth Grae
President, Chief Executive Officer, Director
Dr. Victor Alessi
Independent Director
Mr. Daniel Magraw
Independent Director
Hon. Kathleen Townsend
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 371 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.00

stock-summary
Return on Equity

-15.22%

stock-summary
Price to Book

3.79